157 related articles for article (PubMed ID: 4372371)
41. Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma.
Mukojima T; Gunvén P; Klein G
J Natl Cancer Inst; 1973 Oct; 51(4):1319-21. PubMed ID: 4355608
[No Abstract] [Full Text] [Related]
42. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
[TBL] [Abstract][Full Text] [Related]
43. The relation of the Epstein-Barr virus to Burkitt's lymphoma.
Henle W; Henle G
Zentralbl Bakteriol Orig A; 1972 May; 220(1):40-6. PubMed ID: 4145613
[No Abstract] [Full Text] [Related]
44. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
Sugawara K; Osato T
Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
[No Abstract] [Full Text] [Related]
45. Immunospecificity of antisera against nonhistone nuclear proteins of human lymphoid cells grown in culture.
Platz RD; Riordan SE
Cell Differ; 1981 Mar; 10(2):117-23. PubMed ID: 6261962
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus-positive Japanese Burkitt lymphoma.
Miyoshi I; Hiraki S; Tsubota T; Uno J; Nakamura K; Ota T; Hikita T; Hayashi K; Kataoka M; Tanaka T; Kimura I; Sairenji T; Hinuma Y
Gan; 1978 Jun; 69(3):449-50. PubMed ID: 208908
[No Abstract] [Full Text] [Related]
47. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
48. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
Magrath IT; Henle W
IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
[No Abstract] [Full Text] [Related]
49. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression, and interferon synthesis in human lymphoblastoid cell lines.
Joncas J; Boucher J; Boudreault A; Granger-Julien M
Cancer Res; 1973 Sep; 33(9):2142-8. PubMed ID: 4353485
[No Abstract] [Full Text] [Related]
50. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
Cohen JH; Lenoir GM
Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
[TBL] [Abstract][Full Text] [Related]
51. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
Hampar B; Derge JG; Martos LM; Walker JL
Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
[TBL] [Abstract][Full Text] [Related]
52. The oncogenicity of Epstein-Barr virus.
Miller G
J Infect Dis; 1974 Aug; 130(2):187-205. PubMed ID: 4366977
[No Abstract] [Full Text] [Related]
53. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
Glaser R; Nonoyama M; Decker B; Rapp F
Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
[No Abstract] [Full Text] [Related]
54. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
55. Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors.
Henle W; Henle G; Gunvén P; Klein G; Clifford P; Singh S
J Natl Cancer Inst; 1973 May; 50(5):1163-73. PubMed ID: 4351392
[No Abstract] [Full Text] [Related]
56. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
57. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
Jondal M; Gunven P
Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
Gunvén P; Klein G; Clifford P; Singh S
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
[TBL] [Abstract][Full Text] [Related]
59. The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors.
Patarroyo M; Klein E; Klein G
Cell Immunol; 1982 Feb; 67(1):152-9. PubMed ID: 6176334
[No Abstract] [Full Text] [Related]
60. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
Shapiro IM; Luka J; Andersson-Anvret M; Klein G
Intervirology; 1979; 12(1):19-25. PubMed ID: 227812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
